我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

傣痛消乙醇提取物对高尿酸血症小鼠及痛风性关节炎大鼠的影响(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2020年03期
页码:
11-16
栏目:
实验研究
出版日期:
2020-11-15

文章信息/Info

Title:
Effects of Daitongxiao Ethanol Extract on Hyperuricemia Miceand Gouty Arthritis Rats
作者:
张光云1张超1赵丽娟2李易2刘中勇3陈胤峰2何昕徽2王庆淑2陈普1骆始华1△
1. 云南中医药大学云南省傣医药与彝医药重点实验室,云南 昆明 650500;2. 云南中医药大学第一附属医院,云南 昆明 650021;3. 江西中医药大学附属医院,江西 南昌 3300043
Author(s):
ZHANG Guangyun1 ZHANG Chao1 ZHAO Lijuan2 LI Yi2 LIU Zhongyong3 CHEN Yinfeng2HE Xinhui2 WANG Qingshu2 CHEN Pu1 LUO Shihua1
1. Yunnan Key Laboratory for Dai and Yi Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China;2. The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, China; 3. The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang 3300043, China
关键词:
傣痛消乙醇提取物高尿酸血症急性痛风性关节炎
Keywords:
DTXEE hyperuricemia acute gouty arthritis
分类号:
R285.5
DOI:
10.19288/j.cnki.issn.1000-2723.2020.03.003
文献标识码:
A
摘要:
目的 观察傣痛消乙醇提取物对高尿酸血症小鼠及痛风性关节炎大鼠的影响。方法 选取60只昆明种小鼠随机分为正常对照组、模型组、苯溴马隆组和傣痛消乙醇提取物低、中、高剂量组。模型组及各药物组小鼠均使用30 g/kg酵母进行灌胃造模,正常对照组小鼠给予等容量的蒸馏水;傣痛消乙醇提取物低、中、高剂量组在造模第4天分别以2.6、7.8、23.4 g/kg的傣痛消乙醇提取物灌胃,正常对照组和模型组给予等体积蒸馏水;苯溴马隆组在造模第6天以0.02 g/kg苯溴马隆灌胃,每日1次,连续4 d,末次给药1 h后摘眼球取血。选取60只Wistar大鼠随机分为正常对照组、模型组、秋水仙碱组、傣痛消乙醇提取物低、中、高剂量组。在造模前5 d傣痛消乙醇提取物各组分别以1.8、5.4、16.2 g/kg的傣痛消乙醇提取物灌胃;秋水仙碱组在造模前3 d以0.28 mg/kg秋水仙碱灌胃;正常对照组和模型组给予等体积蒸馏水,每日1次。在末次给药1 h后,模型组及药物组复制急性痛风关节炎模型,造模5 h后麻醉大鼠,腹主动脉取血。分别使用试剂盒检测大鼠和小鼠血清中尿酸(UA)、黄嘌呤氧化酶(XOD)、肌酐(CRE)、尿素氮(BUN)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和白细胞介素1β(IL-1β)的水平;观察大鼠造模前后关节肿胀情况。结果 与正常对照组比较,模型组大鼠和小鼠UA、XOD、CRE、BUN、IL-6、TNF-α和IL-1β均显著升高(P<0.05),急性痛风性关节炎大鼠出现躁动不安、右足抬高、局部红肿、肤温变高和关节肿胀指数显著增加的情况。与模型组比较,傣痛消乙醇提取物低剂量组对高尿酸血症小鼠CRE和急性痛风性关节炎大鼠UA、CRE、IL-6、TNF-α 改善不明显,其余各药物组中UA、XOD、CRE、BUN、IL-6、TNF-α、IL-1β水平均显著降低(P<0.05);药物组急性痛风性关节炎大鼠局部关节肿胀情况较模型组改善明显。结论 傣痛消乙醇提取物对高尿酸血症小鼠和急性痛风性关节炎大鼠具有降尿酸、改善肾功能和抗炎作用。
Abstract:
Objective To observe the effects of Daitongxiao ethanol extract (DTXEE) on hyperuricemia mice and gouty arthritis rats. Methods 60 mice were randomly divided into normal control group, model group, Benbromarone group and low, medium and high dose groups of DTXEE. The model group and drug groups were given 30 g/kg yeast by gavage, while the normal control mice were given distilled water. On the 4th day after modeling, the low, medium and high DTXEE groups were given 2.6, 7.8, 23.4 g/kg DTXEE, respectively, and the model group and normal control group were given distilled water. The Benbromarone group was given 0.02 g/kg benbromarone on the 6th day, administration lasted for 4 d. The blood was taken from the eyeball 1 h after the last administration. 60 Wistar rats were randomly divided into normal control group, model group, colchicine group, and low, medium and high dose groups of DTXEE. The DTXEE groups were gavaged with 1.8, 5.4, 16.2 g/kg of DTXEE respectively for 5 d before modeling, the colchicine group was gavaged with 0.28 mg/kg colchicine for 3 d before modeling, the normal control group and model group were given distilled water once a day. The acute gouty arthritis model was made 1 h later after the last administration in model and drug groups, 5 h after modeling, rats were anesthetized and blood was taken from abdominal aorta. The levels of UA, XOD, CRE, BUN, IL-6, TNF-α and IL-1β in the serum of rats and mice were detected by the kits, and the joint swelling of rats before and after modeling were observed. Results Compared with the normal control group, UA, XOD, CRE, BUN, IL-6, TNF-α, IL-1β in the model group were significantly higher (P<0.05). Restlessness, elevation of right foot, local redness and swelling, increased skin temperature and joint swelling index were observed in acute gouty arthritis rats. Compared with model group, the improvement of CRE in hyperuricemia and UA, CRE, IL-6, TNF-α in acute gouty arthritis were not significant after the intervention of low-dose DTXEE. While the levels of UA, XOD, CRE, BUN, IL-6, TNF-α, IL-1β levels were significantly lower in other drug groups(P<0.05). Moreover, the local joint swelling of rats with acute gouty arthritis in drug groups were improved better than model group. Conclusion DTXEE could reduce uric acid, improve renal function and anti-inflammatory in hyperuricemia mice and acute gouty arthritis rats.

参考文献/References

[1] 叶任高,陆再英. 内科学[M]. 6版. 北京:人民卫生出版社,2004:862-868.
[2] 高小娟,陈仁利,宋一凡. 原发性痛风的临床特点和流行病学研究[J]. 中国卫生标准管理,2018,9(14):15-17.
[3] 林艳芳,张超,叶建州. 傣医临床学[M]. 北京:中国中医药出版社,2007:108-110.
[4] 骆始华. “傣痛消”抗痛风的实验研究及初步临床观察[D]. 昆明:云南中医学院,2012.
[5] 冯志江. “傣痛消”治疗“拢蒙沙喉”风火偏盛型的临床研究[D]. 昆明:云南中医学院,2015.
[6] 陈光亮,张清林,马晓芹,等. 酵母致小鼠高尿酸血症模型[J]. 中国药理学通报,2003(4):467-469.
[7] CODERRE T J,WALL P D. Ankle joint urate arthritis(AJUA)in rats:an alternative animal model of arthritis to that produced by Freund’s adjuvant[J]. Pain,1987,28(3):379-393.
[8]黄敬群,孙文娟,王四旺,等. 尿酸钠致急性痛风性关节炎模型大鼠与槲皮素的抗炎作用[J]. 中国组织工程研究,2012,16(15):2815-2819.
[9] 曾学军. 《2010年中国痛风临床诊治指南》解读[J]. 中国实用内科杂志,2012,32(6):438-441.
[10] 尤力都孜·买买提,热比姑丽·伊斯拉木,阿布都吉力力·阿布都艾尼. 痛风及其动物模型研究初探[J]. 中药药理与临床,2012,28(3):172-173.
[11] 路占忠. 基于有效成分配伍的抗炎复方优选及其对急性痛风性关节炎大鼠NLRP3、IL-1β和TGF-β1表达的影响[D]. 石家庄:河北医科大学,2015.
[12] RAMALLO I A,ZACCHINOS A,FURLAN R L. A rapid TLC autographic method for the detection of xanthine oxidase inhibitors and superoxide scavengers[J]. Phytochem Anal,2006,17(1):15-19.
[13] 张立军. 血清胱抑素C在肾损伤中研究及与血肌酐尿素氮关系的分析[J]. 当代医学,2011,17(2):4-6.
[14] 任昊,刘宏发,刘郑荣. 高尿酸血症和肾脏[J]. 现代中西医结合杂志,2008,17(1),152-154.
[15] 苗蕾. 炎症因子及脂肪因子与高尿酸血症的关系及民族异质性研究[D]. 乌鲁木齐:新疆医科大学,2012.
[16] 杨明功,章秋,郭延云. 老年高尿酸血症与糖尿病[J]. 实用老年医学,2006,20(1):8-10.
[17] SCHETT G,DAYER J M,MANGER B. Interleukin-1 function and role in rheumatic disease[J]. Nat Rev Rheumatol. ,2016,12(1):14-24.
[18] TORRES R,MACDONALD L,CROLL S D,et al. Hyperalgesia,synovitis and multiple biomarkers of inflamation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis[J] . Ann Rheum Dis,2009,68(10):1602-1608.

备注/Memo

备注/Memo:
收稿日期: 2020 - 05- 13 基金项目: 国家自然科学基金项目(81660781);国家中医药管理局国家中医药研究基地业务建设科研专项课题 (JDZX2015248);云南省科技人才和平台计划项目(院士专家工作站)(云科外发(2016)1号);云南省傣医药与 彝医药重点实验室开放课题(2017DG-K2) 第一作者简介: 张光云(1993-),女,在读硕士研究生,研究方向:民族医学。 △通信作者: 骆始华,E-mail:834007250@qq.com
更新日期/Last Update: 2020-11-15